Latest news

16 Jan 2020 Immuno-oncology
Highly mutated cancers in evolutionary battle with immune system
15 Jan 2020 Breast
Palbociclib receives NICE approval as combination therapy for advanced breast cancer
9 Jan 2020 Emerging technologies
Artificial intelligence algorithm could be used to diagnose brain tumors
7 Jan 2020 Lung
KEYNOTE-604 trial demonstrates mixed results for pembrolizumab in small cell lung cancer

Video

View all videos

9 Dec 2019 Diagnostics
How could comprehensive genomic profiling bring cancer from uncertainty to focus?

Video

View all videos

Features

Interviews

Spotlights

Journal articles

Stay up to date

Upcoming event

Molecular Analysis for Personalised Therapy Congress 2020

October 8, 2020 – October 10, 2020

Amsterdam, Netherlands

View all

Upcoming event

ESMO World Congress of Gastrointestinal Cancer 2020

July 1, 2020 – July 4, 2020

Barcelona, Spain

View all

Tweets

Oncology Central @OncologyCentral·

What role could artificial intelligence play in advancing cancer clinical trials? We recently spoke to @woutbrusselaers to find out. Access the full interview here: https://t.co/YnFsHpk298 @deep6ai

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Our mission statement

At Oncology Central we are dedicated to advancing oncology by publishing trusted, engaging and insightful resources for the global oncology community.

Learn more

Highly mutated cancers in evolutionary battle with immune system

Palbociclib receives NICE approval as combination therapy for advanced breast cancer

Artificial intelligence algorithm could be used to diagnose brain tumors

KEYNOTE-604 trial demonstrates mixed results for pembrolizumab in small cell lung cancer

The best of 2019: an A–Z of cancer research and care

The future of liquid biopsies: an interview with Bob Li

Pharma, President, Patients: the cancer cost conundrum

How could a “pre-cancer genome atlas” transform cancer prevention?

Panel discussion: the future of oncology

Unlocking the power of the cancer genome: an interview with Phil Febbo, Illumina Inc.

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Video

How could comprehensive genomic profiling bring cancer from uncertainty to focus?

Video

Login

Latest news

Highly mutated cancers in evolutionary battle with immune system

Palbociclib receives NICE approval as combination therapy for advanced breast cancer

Artificial intelligence algorithm could be used to diagnose brain tumors

KEYNOTE-604 trial demonstrates mixed results for pembrolizumab in small cell lung cancer

Featured articles

The best of 2019: an A–Z of cancer research and care

The future of liquid biopsies: an interview with Bob Li

Pharma, President, Patients: the cancer cost conundrum

How could a “pre-cancer genome atlas” transform cancer prevention?

Panel discussion: the future of oncology

Unlocking the power of the cancer genome: an interview with Phil Febbo, Illumina Inc.

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Video

How could comprehensive genomic profiling bring cancer from uncertainty to focus?

Video

Lung Cancer Ambition Alliance with Giorgio Scagliotti

In Focus: lung cancer

How could comprehensive genomic profiling bring cancer from uncertainty to focus?

In Focus: lung cancer

Addressing unmet needs in pancreatic cancer with Pascal Hammel

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Features

Interviews

Spotlights

Journal articles

Stay up to date

Oncology Central Newsletter